Clinical Trials Logo

Filter by:
NCT ID: NCT01041677 Completed - Obesity Clinical Trials

A Study of the Safety of R256918 in Obese Patients

Start date: February 2008
Phase: Phase 2
Study type: Interventional

This study investigates the safety of 12 weeks of treatment with R256918, in obese patients (JNJ-16269110 and R256918 are different names for the same molecule). The primary objective of the study is to investigate mean changes in Hepatic Triglyceride Content (HTGC), which is the fat content of the liver, from baseline to week 6 and 12 by 1H-Magnetic Resonance Spectroscopy (MRS), a specialized non invasive radiology test. Additional measures include body mass index (BMI), fasting glucose,lipid levels, and blood pressure. Safety assessments performed during the trial include laboratory tests, vital sign measurements, and adverse event reporting.

NCT ID: NCT01040741 Completed - Clinical trials for A New Flu Virus of Swine Origin

Observational Safety Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

Start date: December 2009
Phase: N/A
Study type: Observational

This is an observational safety study of a prophylactic use of Flu Egg Derived Adjuvanted Swine Origin A(H1N1) Vaccine in subjects 6 months of age and older. Subjects may receive either 1 or 2 doses: children and elderly will receive 2 doses and adults will receive either 1 or 2 doses.

NCT ID: NCT01040728 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

Start date: January 2010
Phase: Phase 3
Study type: Interventional

The study is intended to characterize the lung function profile of BI1744 in Chronic Obstructive Pulmonary Disease (COPD) patients where patients will perform pulmonary function tests at regular intervals for 24 hours at the end of a 6 week treatment period. Each patient will receive all four treatments.

NCT ID: NCT01040403 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD)

Start date: January 2010
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to determine the optimum once daily dose of BI 1744 CL and tiotropium in free dose combination (delivered by the Respimat inhaler) after four week treatment in patients with COPD.

NCT ID: NCT01039376 Terminated - Clinical trials for Leukaemia, Lymphocytic, Chronic

Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy

PROLONG
Start date: May 6, 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study was to determine if maintenance therapy with ofatumumab would prolong remission in patients with CLL who have responded to second or third line treatment. This study would also evaluate the safety of ofatumumab maintenance compared to observation (the current standard of care). This study was co-developed with the HOVON and NORDIC CLL group and would be conducted as a collaborative effort with GSK.

NCT ID: NCT01038765 Completed - Clinical trials for Depressive Disorder, Major

Mindfulness Based Cognitive Therapy for Recurrent Depression

Start date: January 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effectiveness and possible mediating factors of Mindfulness Based Cognitive Therapy (MBCT) for recurrent depression.

NCT ID: NCT01037829 Completed - Influenza Clinical Trials

Novartis Pandemic Influenza A (H1N1) Vaccine(s) Observational Comparative Safety Study

Start date: January 2010
Phase: N/A
Study type: Observational

The primary objective of this observational, comparative safety study is to evaluate the safety of the Novartis Pandemic Influenza A (H1N1) vaccine in pregnant women and their off spring, followed for up to 3 months of age as compared to pregnant women who have not received the Novartis Pandemic Influenza A (H1N1) vaccine. This study will be conducted at investigative sites within the Netherlands, Italy, and Argentina.

NCT ID: NCT01037309 Completed - Clinical trials for Duchenne Muscular Dystrophy

Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)

Start date: December 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to see whether PRO044 is safe and effective to use as medication for DMD patients with a mutation around location 44 in the DNA for the dystrophin protein.

NCT ID: NCT01037231 Completed - Clinical trials for Primary Hyperoxaluria

Phase 2/3 Oxabact Study

Start date: December 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to determine if Oxalobacter formigenes is effective at lowering urinary oxalate levels in patients with primary hyperoxaluria.

NCT ID: NCT01036438 Completed - Venous Leg Ulcers Clinical Trials

Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers

Start date: December 2009
Phase: Phase 4
Study type: Interventional

Compare the efficacy of using an absorbent foam silver dressing (Mepilex Ag) versus the equivalent dressing without silver in subjects suffering from venous leg ulcer or mixed ulcer with an ABPI ≥ 0.8 and with inflammatory signs. Efficacy will be defined as absolute wound size reduction.